New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells.

Autor: Ciocan-Cartita, Cristina Alexandra¹ (AUTHOR), Jurj, Ancuta¹ (AUTHOR), Zanoaga, Oana¹ (AUTHOR), Cojocneanu, Roxana¹ (AUTHOR), Pop, Laura-Ancuta¹ (AUTHOR), Moldovan, Alin¹ (AUTHOR), Moldovan, Cristian² (AUTHOR), Zimta, Alina Andreea² (AUTHOR), Raduly, Lajos¹ (AUTHOR), Pop-Bica, Cecilia¹ (AUTHOR), Buse, Mihail² (AUTHOR), Budisan, Liviuta¹ (AUTHOR), Virag, Piroska³ (AUTHOR), Irimie, Alexandru^4,5 (AUTHOR), Diaz, Sandra Martha Gomez⁶ (AUTHOR), Berindan-Neagoe, Ioana^1,7 (AUTHOR) ioananeagoe29@gmail.com, Braicu, Cornelia¹ (AUTHOR)

Publikováno v: Journal of Experimental & Clinical Cancer Research (17569966). 11/13/2020, Vol. 39 Issue 1, p1-16. 16p.

Correction to: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells

Autor: Cristina Alexandra Ciocan-Cartita, Ancuta Jurj, Oana Zanoaga, Roxana Cojocneanu, Laura-Ancuta Pop, Alin Moldovan, Cristian Moldovan, Alina Andreea Zimta, Lajos Raduly, Cecilia Pop-Bica, Mihail Buse, Liviuta Budisan, Piroska Virag, Alexandru Irimie, Sandra Martha Gomes Dias, Ioana Berindan-Neagoe, Cornelia Braicu

Publikováno v: Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-1 (2020)

An amendment to this paper has been published and can be accessed via the original article.

Externí odkaz: https://doaj.org/article/95fe0e4030df4f9080b760d96324f7a2

Investigating the combinatory effect of Sclerocarya birrea with doxorubicin against selected colorectal cancer cell lines

Autor: Thembelihle Nxasana, Innocensia Mangoato, Patriciah Masiu, Abhay Mishra, Motlalepula Matsabisa

Publikováno v: Drug Target Insights, Vol 18, Iss 1 (2024)

Introduction: Colorectal cancer incidences continue to increase annually, worldwide. Herbal plants with antiproliferative properties received research interest as agents that can be adjuvant therapies with chemotherapy drugs to enhance their efficacy

Externí odkaz: https://doaj.org/article/0e72a6d1e9894e3db028d2e3d7504741

Correction to: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells.

Autor: Ciocan-Cartita CA; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Jurj A; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Zanoaga O; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Cojocneanu R; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Pop LA; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Moldovan A; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Moldovan C; MedFuture Research Center for Advanced Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Zimta AA; MedFuture Research Center for Advanced Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Raduly L; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Pop-Bica C; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Buse M; MedFuture Research Center for Advanced Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Budisan L; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Virag P; Laboratory of Radiotherapy, Radiobiology and Tumor Biology, 'Prof. Dr. Ion Chiricuta' Oncology Institute, Cluj-Napoca, Romania., Irimie A; Department of Surgical Oncology and Gynecological Oncology, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Surgery, 'Prof. Dr. Ion Chiricuta' Oncology Institute, Cluj-Napoca, Romania., Gomes Dias SM; Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Sao Paulo, 13083-970, Brazil., Berindan-Neagoe I; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania. ioananeagoe29@gmail.com.; Department of Functional Genomics and Experimental Pathology, 'Prof. Dr. Ion Chiricuta' Oncology Institute, Cluj-Napoca, Romania. ioananeagoe29@gmail.com., Braicu C; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Publikováno v: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2020 Dec 17; Vol. 39 (1), pp. 287. Date of Electronic Publication: 2020 Dec 17.

New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells

Autor: Cristian Moldovan, Sandra Martha Gomes Dias, Roxana Cojocneanu, Mihail Buse, Oana Zanoaga, Ioana Berindan-Neagoe, Piroska Virag, Laura-Ancuta Pop, Alexandru Irimie, Liviuta Budisan, Cecilia Pop-Bica, Ancuta Jurj, Cornelia Braicu, Cristina Alexandra Ciocan-Cartita, Alin Moldovan, Alina-Andreea Zimta, Lajos Raduly

Publikováno v: Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-16 (2020)

Background Triple negative breast cancer (TNBC) is a heterogeneous disease with aggressive behavior and an unfavorable prognosis rate. Due to the lack of surface receptors, TNBC must be intensely investigated in order to establish a suitable treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::172b1ff9c31edca99dd1787d08909525
http://europepmc.org/articles/PMC7664031